Detection and prevention of hospital-acquired staphylococcal infections in pregnant women and postpartum mothers – experience of “Prof. Dr. Panait Sîrbu” Clinical Hospital of Obstetrics and Gynecology, Bucharest
Depistarea şi prevenţia infecţiilor stafilococice intraspitaliceşti la gravide şi lehuze – experienţa Spitalului Clinic „Prof. Dr. Panait Sîrbu”, Bucureşti
Abstract
The article discusses the detection and prevention of hospital-acquired staphylococcal infections in pregnant women and postpartum mothers at the “Prof. Dr. Panait Sîrbu” Clinical Hospital of Obstetrics and Gynecology, in Bucharest, Romania, with a particular focus on infections caused by Staphylococcus aureus and its antibiotic resistance (MRSA). Screening methods involve bacterial cultures from various body sites (nose, axilla, skin) to detect the presence of staphylococcus. At the “Prof. Dr. Panait Sîrbu” Clinical Hospital, tests are performed on all hospitalized patients, and those who test positive undergo decolonization treatment. In cases of obvious infection, patients are isolated to prevent further transmission. Study results from January 1 to October 31, 2024 show a 4.69% prevalence of staphylococcal infections, with 0.64% caused by MRSA. In the neonatology departments, the contamination rate is lower (0.45%). The article emphasizes the importance of regular screening and preventive measures to reduce the incidence of staphylococcal infections, especially MRSA, among hospitalized patients.Keywords
Staphylococcus aureusinfectionabscesscontaminationpreventiondecolonizationtreatmentRezumat
Acest articol discută despre depistarea şi prevenţia infecţiilor stafilococice intraspitaliceşti la gravide şi lehuze în cadrul Spitalului Clinic de Obstetrică şi Ginecologie „Prof. Dr. Panait Sîrbu” din Bucureşti, cu un focus special pe infecţiile cauzate de Staphylococcus aureus şi rezistenţa acestuia la antibiotice (MRSA). Metodele de depistare includ culturi bacteriologice din diverse zone ale corpului (nas, axile, piele) pentru a detecta prezenţa stafilococului. La Spitalul Clinic „Prof. Dr. Panait Sîrbu”, testele sunt efectuate pentru toate pacientele spitalizate, iar cele cu rezultate pozitive urmează un tratament de decolonizare. În cazul infecţiilor evidente, pacientele sunt izolate pentru a preveni răspândirea. Rezultatele studiului din perioada 1.01.2024-31.10.2024 arată un procentaj de 4,69% cazuri de infecţii stafilococice, dintre care 0,64% sunt cauzate de MRSA. În departamentele de neonatologie, rata de contaminare este mai mică (0,45%). Articolul subliniază importanţa screeningului regulat şi a măsurilor de prevenire pentru a reduce incidenţa infecţiilor stafilococice, în special MRSA, în rândul pacientelor spitalizate.Cuvinte Cheie
Staphylococcus aureusinfecţieabcescontaminareprevenţiedecolonizaretratamentIntroduction
Staphylococci are Gram-positive aerobic organisms. Staphylococcus aureus is the most pathogenic; it typically causes skin infections and sometimes pneumonia, endocarditis and osteomyelitis. It usually leads to the formation of abscesses. Some strains produce toxins that cause gastroenteritis, scalded skin syndrome and even toxic shock syndrome. The diagnosis is made through Gram staining and culture.
Staphylococcus aureus has the ability to cause the formation of vascular thrombi through coagulase (coagulase-positive staphylococci), and these are among the most virulent and dangerous pathogens that also have the capacity to develop resistance to antibiotics(1).
Coagulase-positive staphylococci are found on the skin of approximately 30-40% of the healthy population(2).
Risk factors for staphylococcal infections
Individuals who are predisposed to infections include(3):
- newborns and breastfeeding mothers
- patients with surgical incisions, open wounds or burns
- patients with influenza, chronic bronchopulmonary disorders (e.g., cystic fibrosis, emphysema), leukemia, tumors, chronic skin disorders or diabetes mellitus
- patients with transplants, prostheses or intravascular catheters
- patients receiving treatment with adrenal steroids, irradiation, immunosuppressants, or antitumor chemotherapy
- injecting drug users
- patients suffering from chronic kidney disease and undergoing dialysis.
Methicillin is a semi-synthetic derivative of penicillin, developed in the late 1950s, by modifying penicillin’s structure to provide resistance to penicillinase(4).
The emergence of methicillin-resistant Staphylococcus aureus (MRSA) strains in the 1960s in the UK made the drug clinically ineffective. Methicillin resistance arises due to the acquisition of the mecA or mecC gene by previously susceptible staphylococcal strains(5).
Predisposed patients can be infected with antibiotic-resistant staphylococci from other patients, medical staff, or contaminated objects in hospitals or medical institutions. Transmission through medical staff hands is the most common mode of spread, but airborne transmission can also occur.
Complications and diseases caused by staphylococci
- Staphylococcal skin infections
Skin infections are the most common form of staphylococcal disease:
1. Superficial infections can be diffuse, with pustules and vesicular crusts (impetigo – Figure 1)(1). Common sites of infection include the face (e.g., around the nose and mouth), the flexures, hands, and lower limbs(6).
2. Cellulitis or focal infections with nodular abscesses (boils and carbuncles). Furunculosis is an inflammatory, draining, painful nodule that involves the hair follicle, typically following an episode of folliculitis (Figure 2)(1). A carbuncle is a series of interconnected boils in the subcutaneous tissue(7).
3. Deeper skin abscesses are common. Severe necrotizing skin infections and postoperative wound superinfections can also occur (Figure 3).
4. Neonatal staphylococcal infections
Neonatal infections usually occur within four weeks after birth, including skin lesions with or without exfoliation, bacteremia, meningitis, pneumonia, endocarditis, osteomyelitis, staphylococcal joint infections, and toxic shock syndrome (Figure 4)(8).
Screening for staphylococcal infection
At the “Prof. Dr. Panait Sîrbu” Clinical Hospital of Obstetrics and Gynecology, Bucharest, all hospitalized patients, including pregnant women, undergo screening for staphylococcal colonization or infection, by collecting nasal and axillary cultures, detecting over 80% of cases(9). Patients who test positive and are not medical or surgical emergencies undergo general antibacterial cleaning (antiseptic soap, betadine) and local treatment with fusidic acid, followed by retesting. If hospitalization is required, cleaning is performed in the hospital, and patients with obvious infectious clinical signs are isolated.
In the neonatology departments, a second screening is performed to detect staphylococcal colonization and infection in newborns.
If inflammation or erythema is observed on the skin and postoperative wounds, bacterial cultures are taken, including tests for staphylococcus and decolonization, and the infection prevention procedures are continued(10).
Materials and method
Patients were recruited for the study from those hospitalized in the Obstetrics-Gynecology 1st Ward during the first ten months of 2024, as well as from newborns from the Neonatology Departments (1st and 2nd).
All patients underwent tests (bacterial cultures from the nose and skin in adult patients, and from the nose, ear and skin in newborns).
The isolation of Staphylococcus aureus from wounds, purulent collections, and lochia meets the criteria for postoperative wound infection(11).
All data were recorded and transmitted to the Bucharest Public Health Directorate.
The identification of bacterial cultures was performed in our laboratory. Screening samples for Staphylococcus aureus were analyzed locally on chromogenic culture media, using standardized methods. The presence of Staphylococcus aureus was determined based on phenotypic criteria (pink or purple colonies). This culture medium has a sensitivity of 95.5% and a specificity of 99.4% for detecting Staphylococcus aureus(12).
Missing information
We could not quantify the patients with Staphylococcus aureus positive results detected in the outpatient setting, decolonized, or treated at home who then tested negative on retesting. Therefore, the data we provide do not have the sensitivity to describe the level of contamination in the general population, but offer a “snapshot” of the contamination level among obstetrical patients hospitalized at the “Prof. Dr. Panait Sîrbu” Clinical Hospital of Obstetrics and Gynecology, Bucharest.
Results
The number of hospitalized patients from 1.01.2024 to 31.10.2024 in the Obstetrics-Gynecology 1st Ward, including pregnant women, parturients and postpartum women, was 2193.
The number of newborns hospitalized from 1.01.2024 to 31.10.2024 in the Neonatology Departments (1st and 2nd) was 1894 (Figure 5).
Staphylococcus aureus was detected in 103 cases, with the following monthly distribution: 4.69% total prevalence of staphylococcal infection; 0.64% prevalence of MRSA.
There were detected 14 MRSA-positive patients of the cases above, with the following sites of detection: 11 from nasal secretions, two from skin, and one from lochia cultures, which is about 14% of the cases. The weighted average in the general European population is 17.4%(13).
In the neonatology departments, the screening results were very good, with 13 cases of Staphylococcus aureus contamination detected, of which nine cases were MRSA positive.
The prevalence of MRSA-positive cases in the general neonatal population is estimated at 1.5%(14), while in our case the prevalence in the neonatology departments was 0.45%.
Conclusions
1. The colonization rate with positive MRSA in pregnant women is, on average, 4.3%, according to international literature(15). In our hospital, the contamination rate with MRSA was 0.64%.
2. MRSA-positive colonization in neonatology departments ranges from 0.65% to 8.45% according to international literature(16). In our hospital, it was 0.45%.
3. The data obtained confirm the effectiveness of staphylococcal infection screening through the small number of contaminations in hospitalized obstetrical patients, further validated by the small number of MRSA contaminations in newborns.
Measures to increase the effectiveness of preventing staphylococcal infection:
a) Screening, individual isolation, cohort isolation of patients, and the use of gloves, gowns and face masks.
b) Hand hygiene, including the use of antiseptics with water or alcohol-based hand gel, in the absence of water.
c) Hygiene of the living environment, including cleaning, disinfection and sterilization procedures.
Autori pentru corespondenţă: Bogdan Botezatu E-mail: bogdan_zone@yahoo.com
CONFLICT OF INTEREST: none declared.
FINANCIAL SUPPORT: none declared.
This work is permanently accessible online free of charge and published under the CC-BY.
Bibliografie
-
Bush LM, Vazquez-Pertejo MT. Staphylococcal Infections. 2023. https://www.msdmanuals.com/professional/infectious-diseases/gram-positive-cocci/staphylococcal-infections
-
Rigarlsford JF. Chapter 8: Microbiological monitoring of cleaning and disinfection in food plants. In: Mead GC (Ed.). Microbiological Analysis of Red Meat, Poultry and Eggs. Woodhead Publishing, 2007;165-82.
-
Trilla A, Miro JM. Identifying high risk patients for Staphylococcus aureus infections: skin and soft tissue infections. J Chemother. 1995l:7 Suppl 3:37-43.
-
Shanson DC. Antibiotic-resistant Staphylococcus aureus. J Hosp Infect. 1981;2(1):11-36.
-
García-Álvarez L, Holden MT, Lindsay H, et al. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis. 2011;11(8):595-603.
-
NHS Inform. Impetigo. 2020. https://www.nhsinform.scot/illnesses-and-conditions/infections-and-poisoning/impetigo
-
Zimakoff J, Rosdahl VT, Petersen, Scheibel WJ. Recurrent staphylococcal furunculosis in families. Scand J Infect Dis. 1988;20(4):403-5.
-
De Rose DU, Pugnaloni F, Martini L, et al. Staphylococcal Infections and Neonatal Skin: Data from Literature and Suggestions for the Clinical Management from Four Challenging Patients. Antibiotics (Basel). 2023;12(4):632.
-
Coello R, Jiménez J, García M, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis. 1994;13(1):74-81.
-
Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362(1):9-17.
-
National Healthcare Safety Network, Centers for Disease Prevention and Control. Surgical Site Infection Event (SSI). 2024. https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf
-
Gaillot O, Wetsch M, Fortineau N, Berche P. Evaluation of CHROMagar Staph. aureus, a new chromogenic medium, for isolation and presumptive identification of Staphylococcus aureus from human clinical specimens. J Clin Microbiol. 2000;38(4):1587-91.
-
European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe in 2014. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). 2015. https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/antimicrobial-resistance-europe-2014.pdf
-
Zervou FN, Zacharioudakis IM, Ziakas PD, Mylonakis E. MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis. Pediatrics. 2014;133(6):e1015–23.
-
Bauters E, Jonckheere S, Dehaene I, Vandecandelaere P, Argudín MA, Page G. Prevalence and clinical relevance of colonization with methicillin-resistant Staphylococcus aureus in the obstetric population. J Matern Fetal Neonatal Med. 2022;35(25):8186-8191.
-
Seybold U, Halvosa JS, White N, et al. Emergence of and risk factors for methicillin-resistant Staphylococcus aureus of community origin in intensive care nurseries. Pediatrics. 2008;122(5):1039–46.